Covers taxonomy, ethnobotany, cultivation, phytochemistry, pharmacology, clinical trials, toxicology, and commercial aspects of Rhodiola rosea
Provides a meta-analysis of clinical trials and discusses experimentation in clinical practice
Examines the use of R. rosea in treating depression and anxiety disorders, for systemic functions, to augment cancer treatment, and in aerospace medicine
Includes unique chapters on phytopathology and commercialization.


Taxonomy of Rhodiola rosea L., with Special Attention to Molecular Analyses of Nunavik (Québec) Populations; Alain Cuerrier, Mariannick Archambault, Michel Rapinski, and Anne Bruneau
Ethnobotany and Conservation of Rhodiola Species; Alain Cuerrier, Youri Tendland, and Michel Rapinski
Phytochemistry of Rhodiola rosea; Fida Ahmed, Vicky Filion, Ammar Saleem, and John T. Arnason
Cultivation of Rhodiola rosea in Europe; Bertalan Galambosi
Rhodiola rosea Cultivation in Canada and Alaska; Kwesi Ampong-Nyarko
Diseases of Wild and Cultivated Rhodiola rosea; Sheau-Fang Hwang, Stephen E. Strelkov, Kwesi Ampong-Nyarko, and Ron J. Howard
Biotechnology of Rhodiola rosea; Zsuzsanna György
Pharmacological Activities of Rhodiola rosea; Fida Ahmed, Steffany A.L. Bennett, and John T. Arnason
Evidence-Based Efficacy and Effectiveness of Rhodiola SHR-5
Extract in Treating Stress- and Age-Associated Disorders; Alexander Panossian and Georg Wikman
Rhodiola rosea in Psychiatric and Medical Practice; Patricia L. Gerbarg, Petra A. Illig, and Richard P. Brown
Toxicology and Safety of Rhodiola rosea; Hugh Semple and Brandie Bugiak
Commercialization of Rhodiola rosea; Nav Sharma and Raimar Loebenberg
Index